Trial record 12 of 18 for:    Open Studies | "Gonorrhea"

Risk Assessment of Long-Haul Truck Drivers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Wake Forest School of Medicine.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
University of Alabama at Birmingham
Information provided by:
Wake Forest School of Medicine
ClinicalTrials.gov Identifier:
NCT00381992
First received: September 26, 2006
Last updated: January 14, 2010
Last verified: January 2010
  Purpose

International studies have repeatedly documented a substantial prevalence of sexual risk behaviors and high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI) ranging from 5%-56% amongst long-distance truck drivers ("truckers") living in diverse international settings including India, Bangladesh, South Africa, China, Laos and Thailand. The prevalence of sexual risk factors and STI/HIV in US drivers is unknown. This proposal will provide both qualitative and quantitative data on HIV risk behaviors by interviewing and testing truckers working for established long-distance trucking firms, the sector which accounts for most of the jobs in the trucking and warehousing industry in the United States. The data obtained from this study will be used to inform the development of an HIV prevention intervention for long-haul truck drivers.


Condition
Gonorrhea
Chlamydia Infections
Hepatitis B
Hepatitis C
Diabetes Mellitus
Hypertension
Obesity
HIV Infections
Hyperlipidemia

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Risk Assessment of Long-Haul Truck Drivers

Resource links provided by NLM:


Further study details as provided by Wake Forest School of Medicine:

Estimated Enrollment: 337
Study Start Date: September 2005
Estimated Study Completion Date: August 2010
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Detailed Description:

The study proposed in this R34 application will address the following specific aims:

Specific Aim 1. To perform focus groups and in-depth interviews with long-haul truck drivers to guide development of both a behavioral risk assessment instrument and an acceptable HIV/STI screening protocol for long-haul truckers.

Specific Aim 2. To perform in-depth interviews with trucking industry executives to determine barriers to routine HIV/STI assessment and screening of their employees.

Specific Aim 3. To perform a pilot phase with a subsample of long-haul truck drivers characterized by the following steps: TTM-based "cognitive interviews" (N=5); pilot testing of the survey and biomedical screening protocol (N=15); and a follow-up focus group (N=8)

Specific Aim 4. To assess a sample of (N=300) truck drivers for general health and sexual risk behaviors using the adapted theory-based survey and to determine the prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

American long-haul truck drivers affiliated with participating companies or presenting as clients at participating truck stops.

Criteria

Inclusion Criteria:

  1. Long-haul truck driver as defined as a driver, part-time or full-time, who drives a truck across state lines (interstate)
  2. English speaking
  3. Age 21 or greater
  4. Willing to participate
  5. Able to provide written informed consent

Exclusion Criteria:

  1. Does not fit definition of truck driver in inclusion criteria #1
  2. Unwilling to participate
  3. Unwilling or unable to provide informed consent
  4. Unable to understand or speak English
  5. Age < 21 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00381992

Contacts
Contact: Laura H Bachmann, MD, MPH 336-716-3100 lbachman@wfubmc.edu

Locations
United States, North Carolina
Wake Forest University Health Sciences Recruiting
Winston-Salem, North Carolina, United States, 27157
Principal Investigator: Laura H Bachmann, MD, MPH         
Sponsors and Collaborators
Wake Forest School of Medicine
University of Alabama at Birmingham
Investigators
Principal Investigator: Laura H Bachmann, MD, MPH Wake Forest School of Medicine
  More Information

No publications provided

Responsible Party: Laura Hinkle Bachmann, MD, MPH, Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT00381992     History of Changes
Other Study ID Numbers: F060815005, 5R34MH073411-03
Study First Received: September 26, 2006
Last Updated: January 14, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Wake Forest School of Medicine:
sexual risk behavior
diabetes mellitus
hypertension
obesity
human immunodeficiency virus
hyperlipidemia
chlamydia

Additional relevant MeSH terms:
Infection
Communicable Diseases
Hypertension
Diabetes Mellitus
Hepatitis
Hepatitis A
Obesity
HIV Infections
Acquired Immunodeficiency Syndrome
Hepatitis C
Hepatitis B
Hyperlipidemias
Chlamydia Infections
Vascular Diseases
Cardiovascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on September 18, 2014